RIM
VRTX icon

Redwood Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Redwood Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,074
Closed -$373K – 396
2023
Q3 		$373K Buy
+1,074
New +$376K 0.03% 288

Other funds holding VRTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Redwood Investment Management's VRTX Position: Q4 2023 in Review

Redwood Investment Management sold out of Vertex Pharmaceuticals (VRTX) in Q4 2023, closing a stake of 1,074 shares — an estimated $373K sold.

Redwood Investment Management first reported a position in VRTX in Q3 2023 and held it in 1 quarter. The position peaked at $373K in Q3 2023. 1,439 funds tracked by Wall St. Rank hold VRTX as of Q4 2023.

  • Redwood Investment Management reported no remaining Vertex Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Redwood Investment Management sold 1,074 Vertex Pharmaceuticals shares in Q4 2023, an estimated $373K.
  • Redwood Investment Management first reported a position in Vertex Pharmaceuticals in Q3 2023 and held it in 1 quarter.
  • Redwood Investment Management's Vertex Pharmaceuticals position peaked at $373K in Q3 2023.
  • 1,439 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2023.

Based on Redwood Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.